Discovery Suggests a New Way to Prevent HIV from Infecting Human Cells

July 2011
International Journal of Virology;2011, Vol. 7 Issue 2, p72
Academic Journal
No abstract available.


Related Articles

  • Human Cytomegalovirus Tegument Protein pp65 Is Detected in All Intra- and Extra-Axial Brain Tumours Independent of the Tumour Type or Grade. Libard, Sylwia; Popova, Svetlana N.; Amini, Rose-Marie; Kärjä, Vesa; Pietiläinen, Timo; Hämäläinen, Kirsi M.; Sundström, Christer; Hesselager, Göran; Bergqvist, Michael; Ekman, Simon; Zetterling, Maria; Smits, Anja; Nilsson, Pelle; Pfeifer, Susan; de Ståhl, Teresita Diaz; Enblad, Gunilla; Ponten, Fredrik; Alafuzoff, Irina // PLoS ONE;Sep2014, Vol. 9 Issue 9, p1 

    Human cytomegalovirus (HCMV) has been indicated being a significant oncomodulator. Recent reports have suggested that an antiviral treatment alters the outcome of a glioblastoma. We analysed the performance of commercial HCMV-antibodies applying the immunohistochemical (IHC) methods on brain...

  • RESULTADO EXITOSO DE UN PROGRAMA DE TUTORÍA PERSONALIZADA DE INVESTIGACIÓN EN MEDICINA FAMILIAR. Sandoval Magaña, M. A.; Gutiérrez Román, E. A.; Guzmán Pantoja, J. E.; Robles Romero, M. A. // Archivos en Medicina Familiar;abr-jun2011, Vol. 13 Issue 2, p92 

    We analyzed the thesis during the period from 2006 to 2010. We identified the papers presented in poster form, papers submitted for publication and published a total of 86 thesis submitted to the Documentation Centre on Health of the Family Medicine Unit No. 51, Guadalajara, Jalisco. Mexico of...

  • Linfoma de Burkitt, presentación de un caso y abordaje diagnóstico. Aragón-Flores, Mariana; Pérez-Zincer, Fernando; Amézquita-Pérez, Salvador; Roldán, Alfonso; Gaspar-López, Arturo // Revista de Sanidad Militar;nov/dic2012, Vol. 66 Issue 6, p272 

    Introduction. Non-Hodgkin lymphoma, Burkitt variety, has a low prevalence, could be one of the first manifestations of HIV (even with normal levels of CD4) and a potential cure up to 60% with treatment with chemotherapy. Case report. We received the February 25, 2010 in the emergency department...

  • On the Effectiveness of Primary Health Care System in Controlling HIV/AIDS in Iran. KARAMOUZIAN, Mohammad; MOTAGHIPISHEH, Shahrzad; HAGHDOOST, Ali-Akbar; JOULAEI, Hassan; MOTAZEDIAN, Nasrin // Iranian Journal of Public Health;Jul2013, Vol. 42 Issue 7, p783 

    A letter to the editor is presented in response to an article related to the effectiveness of primary health care system, published in previous issue.

  • Impact of Sex on the Pharmacokinetics and Pharmacodynamics of 1% Tenofovir Gel. Herold, Betsy C.; Chen, Beatrice A.; Salata, Robert A.; Marzinke, Mark A.; Kelly, Clifton W.; Dezzutti, Charlene S.; McGowan, Ian; Galaska, Beth; Levy, Lisa; Piper, Jeanna M.; Hillier, Sharon; Hendrix, Craig W. // Clinical Infectious Diseases;2/1/2016, Vol. 62 Issue 3, p375 

    Background. Tenofovir (TFV) gel partially protected against human immunodeficiency virus (HIV) in one but not subsequent trials. The disappointing results were attributed largely to poor adherence. However, timing of gel application relative to sex may impact pharmacokinetics and contribute to...

  • Monitoring HIV Prevention Programme Outcomes among Key Populations in Kenya: Findings from a National Survey. Bhattacharjee, Parinita; McClarty, Leigh M.; Musyoki, Helgar; Anthony, John; Kioko, Japheth; Kaosa, Shem; Ogwang, Bernard E.; Githuka, George; Sirengo, Martin; Birir, Sarah; Blanchard, James F.; Muraguri, Nicholas; Isac, Shajy; Moses, Stephen // PLoS ONE;8/27/2015, Vol. 10 Issue 8, p1 

    In preparation for the implementation of the Kenya AIDS Strategic Framework 2014/15-2018/19, the Kenya National AIDS and STI Control Programme facilitated a national polling booth survey as part of a baseline assessment of HIV-related risk behaviours among FSWs, MSM, and PWID, and their...

  • Conceptualizing Community Mobilization for HIV Prevention: Implications for HIV Prevention Programming in the African Context. Lippman, Sheri A.; Maman, Suzanne; MacPhail, Catherine; Twine, Rhian; Peacock, Dean; Kahn, Kathleen; Pettifor, Audrey // PLoS ONE;Oct2013, Vol. 8 Issue 10, p1 

    Introduction:Community mobilizing strategies are essential to health promotion and uptake of HIV prevention. However, there has been little conceptual work conducted to establish the core components of community mobilization, which are needed to guide HIV prevention programming and evaluation....

  • Enterovirus 71 Protease 2Apro Targets MAVS to Inhibit Anti-Viral Type I Interferon Responses. Bei Wang; Xueyan Xi; Xiaobo Lei; Xiaoyan Zhang; Sheng Cui; Jianwei Wang; Qi Jin; Zhendong Zhao // PLoS Pathogens;Mar2013, Vol. 9 Issue 3, p1 

    Enterovirus 71 (EV71) is the major causative pathogen of hand, foot, and mouth disease (HFMD). Its pathogenicity is not fully understood, but innate immune evasion is likely a key factor. Strategies to circumvent the initiation and effector phases of anti-viral innate immunity are well known;...

  • Landmark HIV vote. Coghlan, Andy // New Scientist;5/19/2012, Vol. 214 Issue 2865, p4 

    The article reports that an antiviral drug for the prevention of HIV infection, called Truvada, may be available for use as a pre-exposure prophylaxis pending approval by officials with the U.S. Food and Drug Administration (FDA).


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics